Results 131 to 140 of about 206,257 (301)
Pelvic Ultrasound for Predicting Endometrial Neoplasia in Premenopausal Abnormal Uterine Bleeding
Journal of Ultrasound in Medicine, EarlyView.Objectives Although ultrasound is the first line imaging modality for abnormal uterine bleeding (AUB), there is a lack of consensus on its predictiveness for premenopausal endometrial pathology. This study aims to determine the predictiveness of pelvic ultrasound for endometrial neoplasia and cancer precursor lesions in premenopausal patients ...
Jessica Grubman +7 more
wiley +1 more source
Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
, 2009 Roberto Cesareo1, Clemente Napolitano1, Mario Iozzino21Department of Internal Medicine, 2Department of Radiology, S.M. Goretti Hospital, Latina, ItalyAbstract: Osteoporosis is a progressive and debilitating disease characterized by a massive bone loss ...
Roberto Cesareo +2 more
core
When Age and Morphology Mislead: Flat Vulvar Melanoma In Situ in a Young Woman
JEADV Clinical Practice, EarlyView.ABSTRACT Pigmented vulvar lesions are frequently encountered in clinical practice and are most often benign, particularly in young women presenting with flat lesions. In contrast, vulvar melanoma predominantly affects postmenopausal patients and is typically associated with raised or palpable morphology, features that usually prompt diagnostic ...
M. M. Nicoletti +5 more
wiley +1 more source
The Oncologic Ambivalence of Longevity Interventions in Photoaged Skin
JEADV Clinical Practice, EarlyView.This graphical abstract presents a stage‐dependent framework for longevity interventions in photoaged skin. UV exposure drives progression from photodamage to field cancerization and skin cancer. Systemic interventions may modulate stress‐response pathways throughout the body, whereas energy‐based procedures generate spatially confined responses ...
Erik Senger, Lea Kurzen, Hjalmar Kurzen
wiley +1 more source
Alendronate improves QOL of postmenopausal women with osteoporosis
, 2010 Hisaya Kawate1, Keizo Ohnaka2, Masahiro Adachi1, Suminori Kono3, Hideyuki Ikematsu4, Hisashi Matsuo5, Kazumi Higuchi6, Takehiko Takayama7, Ryoichi Takayanagi11Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu ...
Keizo Ohnaka +3 more
core
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT To identify the determinants of the response to neoadjuvant systemic therapy (NST) in triple‐positive breast cancer (TPBC), we retrospectively enrolled 520 patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer who were treated at The First Affiliated Hospital of Chongqing Medical University between January 2015 ...
Lin‐Rui Miao +7 more
wiley +1 more source
Ovarian cancer screening in the general population. [PDF]
, 2007 Despite significant improvements in therapy, ovarian cancer continues to be a leading cause of death amongst women with gynaecological malignancies. Advanced stage at diagnosis is thought to be a major contributor to mortality.
Menon, U., Menon, Usha Dr
core
Slow‐Phase Nystagmus Velocity as a Risk Factor for Lateral Canal BPPV Recurrence
The Laryngoscope, EarlyView.This study investigated slow‐phase nystagmus velocity (SPV) at initial diagnosis as an objective vestibular predictor for the recurrence of lateral semicircular canal benign paroxysmal positional vertigo (BPPV). Binomial logistic regression analysis demonstrated that an elevated initial SPV is a novel, independent risk factor for recurrence ...
Chung Yoh Kim, Woo Jin Kim
wiley +1 more source
Denosumab: an investigational drug for the management of postmenopausal osteoporosis
, 2008 E Michael LewieckiNew Mexico Clinical Research & Osteoporosis Center, Albuquerque, New Mexico, USAAbstract: Denosumab (AMG 162) is an investigational fully human monoclonal antibody with a high affinity and specificity for receptor activator of ...
E Michael Lewiecki
core